Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Perrigo Company plc    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/14/2021 01/15/2021 01/19/2021 01/20/2021 01/21/2021 Date
44.65(c) 43.71(c) 43.47(c) 43.27(c) 43.42(c) Last
2 470 582 2 426 233 1 217 268 1 205 413 1 315 634 Volume
-3.19% -2.11% -0.55% -0.46% +0.35% Change
More quotes
Financials (USD)
Sales 2020 5 119 M - -
Net income 2020 65,6 M - -
Net Debt 2020 2 747 M - -
P/E ratio 2020 63,9x
Yield 2020 2,06%
Sales 2021 5 198 M - -
Net income 2021 296 M - -
Net Debt 2021 2 247 M - -
P/E ratio 2021 25,1x
Yield 2021 2,23%
Capitalization 5 926 M 5 926 M -
EV / Sales 2020 1,69x
EV / Sales 2021 1,57x
Nbr of Employees 11 200
Free-Float 99,2%
More Financials
Company
Perrigo Company plc develops, produces, and sells therapy and care products. Sales break down by product family as follows: - consumable care products (80%). The group also offers medical diagnostic products. Net sales break down by geographical area between the United States/Canada/Mexico (64.3%), Europe and Australia (35,7%); - generic prescription drugs (20%). At the end of 2019, the group has 93 production... 
Sector
Pharmaceuticals
Calendar
03/04Earnings Release
More about the company
Notations Surperformance© of Perrigo Company plc
Trading Rating : Investor Rating :
More Ratings
All news about PERRIGO COMPANY PLC
01/07INSIDER TRENDS : Insider Purchase Prolongs Perrigo Company Positive Trend
MT
01/06PERRIGO : RBC Capital Downgrades Perrigo Company to Sector Perform From Outperfo..
MT
2020PERRIGO CO PLC : Change in Directors or Principal Officers (form 8-K)
AQ
2020PERRIGO COMPANY PLC : Ex-dividend day for
FA
2020PERRIGO : 'Quitting is better' Campaign Enters its Fourth Year of Partnership wi..
AQ
2020Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corpora..
AQ
2020INSIDER TRENDS : Insider Buying Added to with Purchase of Perrigo Company Stock
MT
2020PERRIGO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
2020PERRIGO : 3Q Earnings Snapshot
AQ
2020Perrigo Company Reports Q3 Adjusted EPS of $0.93, Reaffirms 2020 Outlook
MT
2020PERRIGO CO PLC : Results of Operations and Financial Condition, Financial Statem..
AQ
2020Perrigo's Loses Bid in Irish High Court to Overturn $1.92 Billion Tax Assessm..
MT
2020Perrigo loses bid to quash $1.9 bln Irish back tax demand
RE
2020Irish High Court rejects Perrigo bid to quash 1.6 bln euro back tax bill
RE
2020PERRIGO : to Build New North American Corporate Headquarters on 'Medical Mile' i..
AQ
More news
News in other languages on PERRIGO COMPANY PLC
2019GLAXOSMITHKLINE : Perrigo achète les droits du Prevacid
2019WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
2019Le bénéfice de Johnson & Johnson bondit de 41,8% au deuxième trimestre
2019WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
2019Takeda anticipe une perte en 2019-2020 après le rachat de Shire
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | PRGO | IE00BGH1M568 | MarketScreener
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 52,89 $
Last Close Price 43,42 $
Spread / Highest target 47,4%
Spread / Average Target 21,8%
Spread / Lowest Target -7,88%
EPS Revisions
Managers and Directors
NameTitle
Murray S. Kessler President, Chief Executive Officer & Director
Rolf Allan Classon Chairman
Raymond P. Silcock Chief Financial & Accounting Officer
Thomas Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY PLC-2.91%5 926
JOHNSON & JOHNSON2.76%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.90%202 881